The new probe could prove to be a breakthrough in whole-body imaging – allowing doctors, for example, to noninvasively monitor the growth of tumors in order to assess the effectiveness of anti-cancer therapies. In contrast to other body-scanning techniques, fluorescent-protein imaging does not involve radiation exposure or require the use of contrast agents. The findings are described in the July 17 online edition of Nature Biotechnology.
For the past 20 years, scientists have used a variety of colored fluorescent proteins, derived from jellyfish and corals, to visualize cells and their organelles and molecules. But using fluorescent probes to peer inside live mammals has posed a major challenge. The reason: hemoglobin in an animal's blood effectively absorbs the blue, green, red and other wavelengths used to stimulate standard fluorescent proteins along with any wavelengths emitted by the proteins when they do light up.
To overcome that roadblock, the laboratory of Vladislav Verkhusha, Ph.D., associate professor of anatomy and structural biology at Einstein and the study's senior author, engineered a fluorescent protein from a bacterial phytochrome (the pigment that a species of bacteria uses to detect light). This new phytochrome-based fluorescent protein, dubbed iRFP, both absorbs and emits light in the near-infrared portion of the electromagnetic spectrum– the spectral region in which mammalian tissues are nearly transparent.
The researchers targeted their fluorescent protein to the liver – an organ particularly difficult to visualize because of its high blood content. Adenovirus particles containing the gene for iRFP were injected into mice. Once the viruses and their gene cargoes infected liver cells, the infected cells expressed the gene and produced iRFP protein. The mice were then exposed to near-infrared light and it was possible to visualize the resulting emitted fluorescent light using a whole-body imaging device. Fluorescence of the liver in the infected mice was first detected the second day after infection and reached a peak at day five. (See accompanying images.) Additional experiments showed that the iRFP fluorescent protein was nontoxic.
"Our study found that iRFP was far superior to the other fluorescent proteins that reportedly help in visualizing the livers of live animals," said Grigory Filonov, Ph.D., a postdoctoral fellow in Dr. Verkhusha''''s laboratory at Einstein, and the first author of the Nature Biotechnology paper. "iRFP not only produced a far brighter image, with higher contrast than the other fluorescent proteins, but was also very stable over time. We believe it will significantly broaden the potential uses for noninvasive whole-body imaging."
Dr. Filonov noted that fluorescent-protein imaging involves no radiation risk, which can occur with standard x-rays and computed tomography (CT) scanning. And unlike magnetic resonance imaging (MRI), in which contrasting agents must sometimes be swallowed or injected to make internal body structures more visible, the contrast provided by iRFP is so vibrant that contrasting agents are not needed.
The study, "Bright and stable near-infrared fluorescent protein for in vivo imaging," was published in the July 17 online edition of Nature Biotechnology. Other Einstein researchers involved in the study were Kiryl Piatkevich, Ph.D., Li-Min Ting, Ph.D., Jinghang Zhang, M.D., and Kami Kim, M.D. This research was carried out at the Gruss Lipper Biophotonics Center and supported by grants from the National Institute of General Medicine Sciences of the National Institutes of Health.About Albert Einstein College of Medicine of Yeshiva University
Kim Newman | Newswise Science News
First images of dolphin brain circuitry hint at how they sense sound
07.07.2015 | Emory Health Sciences
Two are better than one – another checkpoint enzyme for flawless cell division
07.07.2015 | Universität Basel
Mit dem erfolgreich abgeschlossenen Test aller siebzig Magnetspulen ist jetzt die Funktion der technologischen Schlüsselkomponente für das Fusionsexperiment...
Eine internationale Kooperation hat es geschafft, mit Synchrotronlicht komplexe Magnetisierungsmuster in gewickelten magnetischen Schichten dreidimensional auszulesen. Dieses Verfahren könnte interessant sein, um hochempfindliche Sensoren für Magnetfelder zu entwickeln, beispielsweise für die medizinische Diagnostik. Die Ergebnisse sind in Nature Communications publiziert.
Feine Strukturen im Inneren von Materialien und biologischen Proben lassen sich heute mit Röntgentomographie gut ermitteln: Dabei werden Schicht für Schicht...
Wissenschaftler erforschen grenzflächenüberschreitende, ultraschnelle Kontrolle von Magnetismus: Eine neue Studie zeigt auf wie die schlagartige Anregung von Gitterschwingungen in einem Kristall die magnetischen Eigenschaften einer atomar dünnen Schicht, die auf seiner Oberfläche aufliegt, verändern kann.
Eine Gruppe von Forschern unter der Leitung von Wissenschaftlern des Max-Planck-Instituts für Struktur und Dynamik der Materie am CFEL in Hamburg, der...
Researchers explore ultrafast control of magnetism across interfaces: A new study discovers how the sudden excitation of lattice vibrations in a crystal can trigger a change of the magnetic properties of an atomically-thin layer that lies on its surface.
A research team, led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter at CFEL in Hamburg, the University of Oxford, and the...
Laut einem spanisch-britischen Forscherteam wäre es sinnvoll, unter großen Brücken Windturbinen zur Stromgewinnung zu verbauen. Denn Modellrechnungen am...
07.07.2015 | Veranstaltungen
06.07.2015 | Veranstaltungen
06.07.2015 | Veranstaltungen